Future perspectives in melanoma research “Melanoma Bridge”, Napoli, November 30th–3rd December 2016

Major advances have been made in the treatment of cancer with targeted therapy and immunotherapy; several FDA-approved agents with associated improvement of 1-year survival rates became available for stage IV melanoma patients. Before 2010, the 1-year survival were quite low, at 30%; in 2011, the ri...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Transl Med
Main Authors: Ascierto, Paolo A., Agarwala, Sanjiv S., Ciliberto, Gennaro, Demaria, Sandra, Dummer, Reinhard, Duong, Connie P. M., Ferrone, Soldano, Formenti, Silvia C., Garbe, Claus, Halaban, Ruth, Khleif, Samir, Luke, Jason J., Mir, Lluis M., Overwijk, Willem W., Postow, Michael, Puzanov, Igor, Sondel, Paul, Taube, Janis M., Thor Straten, Per, Stroncek, David F., Wargo, Jennifer A., Zarour, Hassane, Thurin, Magdalena
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2017
Assuntos:
Meeting Report
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5691855/
https://ncbi.nlm.nih.gov/pubmed/29145885
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12967-017-1341-2
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados